David Henry Mack - 20 May 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ David H. Mack
Issuer symbol
PMVP
Transactions as of
20 May 2021
Net transactions value
-$491,676
Form type
4
Filing time
24 May 2021, 16:52:50 UTC
Previous filing
08 Jun 2021
Next filing
04 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $4,130 +7,793 +316% $0.5300* 10,263 20 May 2021 Direct
transaction PMVP Common Stock Sale $277,455 -7,793 -76% $35.60 2,470 20 May 2021 Direct F1, F2
transaction PMVP Common Stock Options Exercise $3,290 +6,207 +251% $0.5300* 8,677 21 May 2021 Direct
transaction PMVP Common Stock Sale $221,641 -6,207 -72% $35.71 2,470 21 May 2021 Direct F1, F3
holding PMVP Common Stock 227,915 20 May 2021 See footnote F4
holding PMVP Common Stock 56,978 20 May 2021 See footnote F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Options Exercise $0 -7,793 -1.6% $0.000000 492,867 20 May 2021 Common Stock 7,793 $0.5300 Direct F6
transaction PMVP Stock Option (right to buy) Options Exercise $0 -6,207 -1.3% $0.000000 485,074 21 May 2021 Common Stock 6,207 $0.5300 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.99, inclusive.
F4 The shares are held of record by The Mack-Mulligan Revocable Trust, for which the Reporting Person serves as co-trustee.
F5 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust, for which the Reporting Person serves as co-trustee.
F6 The shares subject to the option are fully vested and immediately exercisable.